Swiss National Bank »

Summit Therapeutics shares owned by Swiss National Bank

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Swiss National Bank from 13F filings

Historical chart of Swiss National Bank investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Swiss National Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Swiss National Bank

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1M 275k 4.14
2023-12-31 $718k 275k 2.61
2023-09-30 $568k 304k 1.87
2023-06-30 $763k 304k 2.51